Biogen

Organization

American biotechnology company developing therapies for neurological diseases

4 stories

Experimental Drug Shows First-Ever Reduction in Tau Pathology and Cognitive Benefit in Early Alzheimer's Trial

Scientists Identify Biological Factors Behind Exceptional Memory Retention in Older Adults

Study Concludes Anti-Amyloid Alzheimer's Drugs Have No Clinically Meaningful Effect

Scientists Identify Protein That Drives Brain Aging and Find Potential Way to Block It